Patients aged <= 70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy - Reply
H. Ozer, Patients aged <= 70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy - Reply, J CL ONCOL, 19(5), 2001, pp. 1584-1585